YUHSpace: Dept. of Internal Medicine (내과학교실)

Keyword Cloud

Journal Categories

Hot Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorecta...

Eric Van Cutsem ; Claus-Henning Köhne ; Erika Hitre ; Jerzy Zaluski ; Chung-R... NEW ENGLAND JOURNAL OF MEDICINE, Vol.360(14) : 1408-1417, 2009

PDF Read more

This table browses all dspace content
Issue Date	Title	Journal Title
2022	Updated ARROW data: Pralsetinib in patients (pts) with advanced or metastatic RET-altered thyroid cancer (TC)	ANNALS OF ONCOLOGY
2022	Updated analyses from the CROWN study of first-line lorlatinib vs crizotinib in Asian patients with ALK-positive non-small cell lung cancer (NSCLC)	ANNALS OF ONCOLOGY
2022	Iatrogenic aortic dissection during right transradial intervention in a patient with aberrant right subclavian artery: A case report	WORLD JOURNAL OF CLINICAL CASES
2022	Sarcopenia is associated with cardiovascular risk in patients with COPD, independent of adiposity	EUROPEAN RESPIRATORY JOURNAL
2022	Delirium screening in critically ill patients: validation of the Korean version of the 4 A’s Test	EUROPEAN RESPIRATORY JOURNAL
2022	Adherence to healthy lifestyle behaviors as a preventable risk factor for severe hypoglycemia in people with type 2 diabetes: A longitudinal nationwide cohort study	JOURNAL OF DIABETES INVESTIGATION
2022	Giredestrant (GDC-9545) vs physician choice of endocrine monotherapy (PCET) in patients (pts) with ER+, HER2-locally advanced/metastatic breast cancer (LA/mBC): Primary analysis of the phase II, randomised, open-label acelERA BC study	ANNALS OF ONCOLOGY
2022	Genomic analysis of plasma cell-free DNA in patients with heavily pretreated HER-2+metastatic breast cancer (MBC)	ANNALS OF ONCOLOGY
2022	A phase I-II multicenter, open-label, dose-escalation study to evaluate the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of ABN401 in patients with advanced solid tumors and dose-expansion in patients with non-small cell lung cancer harboring c-MET dysregulation	ANNALS OF ONCOLOGY
2022	Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study	BRITISH JOURNAL OF HAEMATOLOGY
2022	MONARCH 3: Interim overall survival (OS) results of abemaciclib plus a nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+, HER2-advanced breast cancer (ABC)	ANNALS OF ONCOLOGY
2022	ORCHARD platform study: Osimertinib plus datopotamab deruxtecan (Dato-DXd) cohort in patients (pts) with advanced NSCLC (aNSCLC) who have progressed on first-line (1L) osimertinib	ANNALS OF ONCOLOGY
2022	Randomized phase II trial of upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy versus preoperative chemoradiotherapy followed by surgery and adjuvant chemotherapy in locally advanced rectal cancer: KCSG-CO14-10	ANNALS OF ONCOLOGY
2022	Real-world prevalence of MSI-H/dMMR across 6 different tumor types in Asia	ANNALS OF ONCOLOGY
2022	Adjuvant trastuzumab plus pertuzumab (TP) versus trastuzumab (T) alone in patients achieving pathologic complete response after chemotherapy with 쎼	ANNALS OF ONCOLOGY
2022	Effects of screening and treatment improvement on colon cancer survival over 20 years in Korea	ANNALS OF ONCOLOGY
2022	Preliminary results from a phase I study using the bispecific, human epidermal growth factor 2 (HER2)-targeting antibody-drug conjugate (ADC) zanidatamab zovodotin (ZW49) in solid cancers	ANNALS OF ONCOLOGY
2022	Post hoc analysis of pembrolizumab efficacy in potentially platinum ineligible patients with urothelial carcinoma enrolled in KEYNOTE-052 and LEAP-011	ANNALS OF ONCOLOGY
2022	Biological insights into systemic lupus erythematosus through an immune cell-specific transcriptome-wide association study	ANNALS OF THE RHEUMATIC DISEASES
2022	Datopotamab deruxtecan (Dato-DXd), a TROP2 antibody-drug conjugate, vs investigators’ choice of chemotherapy (ICC) in previously-treated, inoperable or metastatic hormone-receptor (HR) positive, HER2-negative (HR+/HER2–) breast cancer: TROPION-Breast01	ANNALS OF ONCOLOGY

This table browses all dspace content

Issue Date

Title

Journal Title

2022

Updated ARROW data: Pralsetinib in patients (pts) with advanced or metastatic RET-altered thyroid cancer (TC)

ANNALS OF ONCOLOGY

2022

Updated analyses from the CROWN study of first-line lorlatinib vs crizotinib in Asian patients with ALK-positive non-small cell lung cancer (NSCLC)

ANNALS OF ONCOLOGY

2022

Iatrogenic aortic dissection during right transradial intervention in a patient with aberrant right subclavian artery: A case report